← TrialMatch
HomeTrials

KOrean Borderline Ovarian Tumor (KOBOT) Registry

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Condition(s)Ovarian Neoplasms
StatusRecruiting
Study typeObservational
SummaryThe aim of this study is to collect data on Korean patients with borderline ovarian tumors.
Who can participateInclusion Criteria: * Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. * All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015 Exclusion Criteria: * Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis
SexFemale
Lead sponsorKangbuk Samsung Hospital
LocationsChangwon, South Korea; Seoul, South Korea; Seoul, South Korea; Seoul, South Korea
Start date1994-12
NCT IDNCT02803970
Official listinghttps://clinicaltrials.gov/study/NCT02803970

🔍 Search all trials →